Survival rates are a way to measure how many people survive a certain type of cancer over time. They cannot tell you exactly what will happen with any one person, but they may help give you a better understanding of how likely it is that treatment will be successful.
These statistics can be confusing, and they may lead you to have more questions. Ask your cancer care team how these numbers might apply to you.
What is a 5-year relative survival rate?
A relative survival rate compares men with the same type and stage of penile cancer to men in the overall population.
For example, if the 5-year relative survival rate for a specific stage of penile cancer is 80%, it means that men who have that cancer are, on average, about 80% as likely as men who don’t have that cancer to live for at least 5 years after being diagnosed.
Where do these numbers come from?
The American Cancer Society relies on information from the Surveillance, Epidemiology, and End Results (SEER) database, maintained by the National Cancer Institute (NCI), to provide survival statistics for different types of cancer.
The SEER database tracks 5-year relative survival rates for penile cancer in the United States, based on how far the cancer has spread. The SEER database, however, does not group cancers by AJCC TNM stages (stage 1, stage 2, stage 3, etc.). Instead, it groups cancers into localized, regional, and distant stages:
- Localized: The cancer is confined to the penis.
- Regional: The cancer has spread outside of the penis to nearby structures or nearby lymph nodes.
- Distant: The cancer has spread to distant parts of the body such as the lungs, liver, or bones.
5-year relative survival rates for penile cancer
These numbers are based on men diagnosed with penile cancer between 2015 and 2021.
SEER Stage |
5-Year Relative Survival Rate |
Localized |
79% |
Regional |
57% |
Distant |
10% |
All SEER stages combined |
65% |